(Reuters) – Abbott Laboratories said on Monday it and DexCom have reached an agreement to settle all patent disputes between the companies related to continuous glucose monitoring devices.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
